Amylin (Q39293507)

From Wikidata

Jump to navigation Jump to search

scientific article published on May 2017

Language	Label	Description	Also known as
English	Amylin	scientific article published on May 2017

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

Europe PubMed Central

Amylin. (English)

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

publication date

1 May 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

57 Suppl 2

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

89-96

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

CGRP and its receptors

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin: Pharmacology, Physiology, and Clinical Potential

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

A second trigeminal CGRP receptor: function and expression of the AMY1 receptor.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Pharmacological discrimination of calcitonin receptor: receptor activity-modifying protein complexes

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Mice lacking the neuropeptide alpha-calcitonin gene-related peptide are protected against diet-induced obesity

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Bench to bedside advances in the 21st century for primary headache disorders: migraine treatments for migraine patients

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Targeting CGRP: A New Era for Migraine Treatment

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Consequences of splice variation on Secretin family G protein-coupled receptor function

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Receptor activity-modifying protein-dependent impairment of calcitonin receptor splice variant Δ(1-47)hCT((a)) function

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Pharmacological characterization of rat amylin receptors: implications for the identification of amylin receptor subtypes.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

A key role for tryptophan 84 in receptor activity-modifying protein 1 in the amylin 1 receptor

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Identification of N-terminal receptor activity-modifying protein residues important for calcitonin gene-related peptide, adrenomedullin, and amylin receptor function

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

An allosteric role for receptor activity-modifying proteins in defining GPCR pharmacology

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Calcitonin and Amylin Receptor Peptide Interaction Mechanisms: INSIGHTS INTO PEPTIDE-BINDING MODES AND ALLOSTERIC MODULATION OF THE CALCITONIN RECEPTOR BY RECEPTOR ACTIVITY-MODIFYING PROTEINS.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Mapping the CGRP receptor ligand binding domain: tryptophan-84 of RAMP1 is critical for agonist and antagonist binding

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Pharmacology of the human CGRP1 receptor in Cos 7 cells

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Calcitonin and calcitonin receptor-like receptors: common themes with family B GPCRs?

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Structure-activity relationships of the N-terminus of calcitonin gene-related peptide: key roles of alanine-5 and threonine-6 in receptor activation

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Receptor activity-modifying protein 1 determines the species selectivity of non-peptide CGRP receptor antagonists

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Calcitonin gene-related peptide (CGRP): a new target for migraine

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin-mediated control of glycemia, energy balance, and cognition

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin activates distributed CNS nuclei to control energy balance

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Effects of amylin on eating and adiposity

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Control of energy homeostasis by amylin

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Pramlintide in the treatment of type 1 and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

The effect of pramlintide acetate on glycemic control and weight in patients with type 2 diabetes mellitus and in obese patients without diabetes: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Progressive reduction in body weight after treatment with the amylin analog pramlintide in obese subjects: a phase 2, randomized, placebo-controlled, dose-escalation study

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Pramlintide treatment reduces 24-h caloric intake and meal sizes and improves control of eating in obese subjects: a 6-wk translational research study

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Inhibition of gastric emptying

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Effect of pramlintide on satiety and food intake in obese subjects and subjects with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

A novel dual amylin and calcitonin receptor agonist, KBP-089, induces weight loss through a reduction in fat, but not lean mass, while improving food preference

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Paraventricular nucleus administration of calcitonin gene-related peptide inhibits food intake and stimulates the hypothalamo-pituitary-adrenal axis

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin reduces food intake more potently than calcitonin gene-related peptide (CGRP) when injected into the lateral brain ventricle in rats

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin receptor signaling in the ventral tegmental area is physiologically relevant for the control of food intake

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Parabrachial CGRP Neurons Control Meal Termination

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Genetic identification of a neural circuit that suppresses appetite

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Lesion of the lateral parabrachial nucleus attenuates the anorectic effect of peripheral amylin and CCK.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Identification of central projections from amylin-activated neurons to the lateral hypothalamus

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin modulates the mesolimbic dopamine system to control energy balance

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Genetically and functionally defined NTS to PBN brain circuits mediating anorexia

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Elucidating an Affective Pain Circuit that Creates a Threat Memory

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

The role of calcitonin gene-related peptide in peripheral and central pain mechanisms including migraine

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin modulates the formalin-induced tonic pain behaviours in rats.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Amylin suppresses acetic acid-induced visceral pain and spinal c-fos expression in the mouse

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Effects of intrathecal amylin on formalin-induced nociception and on cAMP accumulation in the rat embryonic spinal cells.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Reduced nociceptive behavior in islet amyloid polypeptide (amylin) knockout mice

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Pramlintide and the treatment of diabetes: a review of the data since its introduction

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Effect of pramlintide on symptom, catecholamine, and glucagon responses to hypoglycemia in healthy subjects

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

CL/RAMP2 and CL/RAMP3 produce pharmacologically distinct adrenomedullin receptors: a comparison of effects of adrenomedullin22-52, CGRP8-37 and BIBN4096BS.

1 reference

https://api.crossref.org/works/10.1111%2FHEAD.13077

21 January 2018

Identifiers

10.1111/HEAD.13077

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

10 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39293507&oldid=2149668160"